Shin Kong Pharmaceutical: Shareholders holding more than 5% of shares, Hefeng Investment plans to reduce their holdings by no more than 3.2 million shares

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Comments are closed.